Argenica Therapeutics Ltd (AGN) — Financial Flexibility Index
Argenica Therapeutics Ltd (AGN) has a Financial Flexibility Index of -3.14x as of December 2025. Free cash flow of AU$-5.51 Million (operating CF AU$-5.51 Million minus capex AU$0.00) represents -3% of total liabilities (AU$1.76 Million). Check how resilient are Argenica Therapeutics Ltd's assets to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Argenica Therapeutics Ltd Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Argenica Therapeutics Ltd across 6 annual periods. See AGN working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Argenica Therapeutics Ltd (2019–2024)
Year-by-year free cash flow to debt coverage for Argenica Therapeutics Ltd. For the full company profile including market capitalisation, see Argenica Therapeutics Ltd (AGN) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.50x | AU$-5.70 Million | AU$-5.70 Million | AU$3.80 Million | — |
| 2023 | 0.00x | AU$0.00 | AU$-5.06 Million | AU$2.43 Million | ▲ +100.0% |
| 2022 | -1.76x | AU$-3.30 Million | AU$-3.30 Million | AU$1.87 Million | ▲ +61.5% |
| 2021 | -4.57x | AU$-3.36 Million | AU$-3.36 Million | AU$735.91K | ▼ -85.8% |
| 2020 | -2.46x | AU$-1.05 Million | AU$-1.05 Million | AU$425.72K | ▼ -1401.4% |
| 2019 | -0.16x | AU$-58.82K | AU$-58.82K | AU$359.26K | — |